§ Why is VKTX moving today →

Why Viking Therapeutics (VKTX) Stock Fell 3.0% on November 12, 2026

-3.02%$27.58November 12, 2026 · S&P 500 -0.35%
The short answer

Viking Therapeutics (VKTX) stock is down 3.0% to $27.58 in the November 12, 2026 session, a move that is much larger than the S&P 500 ETF (SPY), which is down 0.4% in the same session. This decline appears to be specific to VKTX or its industry, rather than reflecting the overall market. Recent headlines, such as "Viking Therapeutics (VKTX) Heads To Two Conferences, Is The Discount To Analyst Targets Warranted?" (Yahoo), could suggest investor caution about the company’s prospects at these conferences, potentially contributing to the stock's drop.

The news behind it

Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 · The Motley Fool · Nov 13
Viking Therapeutics (VKTX) Heads To Two Conferences, Is The Discount To Analyst Targets Warranted? · Yahoo · Nov 12
Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? · The Motley Fool · Nov 11
Before you buy or sell
Get a second opinion on VKTX
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when VKTX moves
Price, RSI and volume alerts by email or push. Free plan →

Full market recap for November 12, 2026 · What's moving VKTX today

Written from that session's quote and the headlines listed above. Educational, not financial advice.